STAT — Reporting from the frontiers of health and medicine
- Politics Key senators propose an overhaul of how the U.S. prepares for pandemics
- Health It’s too early to tell whether CBD helps against Covid-19 — but researchers worry that won’t stop CBD makers
- Health As Pfizer and BioNTech begin clinical trial of Omicron-based vaccine, timeline to authorization is unclear
- Opinions+ What’s blocking health care boards’ progress in diversity, equity, and inclusion?
- Health Tech Can open datasets help machine learning solve medical mysteries?
- Politics Key senators propose an overhaul of how the U.S. prepares for pandemics
- Health It’s too early to tell whether CBD helps against Covid-19 — but researchers worry that won’t stop CBD makers
- Health As Pfizer and BioNTech begin clinical trial of Omicron-based vaccine, timeline to authorization is unclear
- Opinions+ What’s blocking health care boards’ progress in diversity, equity, and inclusion?
- Health Tech Can open datasets help machine learning solve medical mysteries?
Exclusive analysis of biotech, pharma, and the life sciences
- In the Lab Strong new evidence suggests a virus triggers multiple sclerosis
- First Opinion Researching collagen to help his achy knees, a statistician explores the painfully weak evidence
- Health It’s too early to tell whether CBD helps against Covid-19 — but researchers worry that won’t stop CBD makers
-
- Health As Pfizer and BioNTech begin clinical trial of Omicron-based vaccine, timeline to authorization is unclear
- Politics Insulin giants Eli Lilly and Novo Nordisk boosted their lobbying spending as Democrats eyed pricing reform
- Health New data show those who recovered from Covid-19 were less likely than vaccinated to get infected during Delta wave
- First Opinion Antigen testing has some serious problems. Done right, it could reshape the future of health care
- First Opinion Human reproductive cloning: The curious incident of the dog in the night-time
